Insulin-like Growth Factor-2 (IGF-2) in Fibrosis

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Nov 11

PMID 36358907

Authors

Yuhan Zhu

Lin Chen

Binyu Song

Zhiwei Cui

Guo Chen

Zhou Yu

Baoqiang Song

Affiliations

Soon will be listed here.

Abstract

The insulin family consists of insulin, insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), their receptors (IR, IGF-1R and IGF-2R), and their binding proteins. All three ligands are involved in cell proliferation, apoptosis, protein synthesis and metabolism due to their homologous sequences and structural similarities. Insulin-like growth factor 2, a member of the insulin family, plays an important role in embryonic development, metabolic disorders, and tumorigenesis by combining with three receptors with different degrees of affinity. The main pathological feature of various fibrotic diseases is the excessive deposition of extracellular matrix (ECM) after tissue and organ damage, which eventually results in organic dysfunction because scar formation replaces tissue parenchyma. As a mitogenic factor, IGF-2 is overexpressed in many fibrotic diseases. It can promote the proliferation of fibroblasts significantly, as well as the production of ECM in a time- and dose-dependent manner. This review aims to describe the expression changes and fibrosis-promoting effects of IGF-2 in the skin, oral cavity, heart, lung, liver, and kidney fibrotic tissues.

Citing Articles

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies.

Zhao F, Jiang X, Li Y, Huang T, Xiahou Z, Nie W Front Immunol. 2025; 15:1500153.

PMID: 39896800 PMC: 11782144. DOI: 10.3389/fimmu.2024.1500153.

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Li Y, Liu R, Zhao Z Pharmaceutics. 2025; 17(1).

PMID: 39861756 PMC: 11769103. DOI: 10.3390/pharmaceutics17010109.

Exploring a pico-well based scRNA-seq method (HIVE) for simplified processing of equine bronchoalveolar lavage cells.

Fegraeus K, Riihimaki M, Nordlund J, Akula S, Wernersson S, Raine A PLoS One. 2025; 20(1):e0317343.

PMID: 39854349 PMC: 11760581. DOI: 10.1371/journal.pone.0317343.

The Significance of Plant Nutrition in the Creation of the Intestinal Microbiota-Prevention of Chronic Diseases: A Narrative Review.

Jovandaric M, Jovanovic K, Raus M, Babic S, Igic T, Kotlica B Medicina (Kaunas). 2025; 60(12.

PMID: 39768848 PMC: 11678629. DOI: 10.3390/medicina60121969.

Mechanical stretch-induced IGF2 overexpression in epidermal keratinocytes promotes hypertrophic scar formation through the IGF1R/p-c-Jun axis.

Zhu Y, Chen L, Song B, Cui Z, Chen G, Dou W Int J Biol Sci. 2025; 21(1):109-127.

PMID: 39744430 PMC: 11667814. DOI: 10.7150/ijbs.91661.

References

Bohnsack R, Warejcka D, Wang L, Gillespie S, Bernstein A, Twining S . Expression of insulin-like growth factor 2 receptor in corneal keratocytes during differentiation and in response to wound healing. Invest Ophthalmol Vis Sci. 2014; 55(12):7697-708. PMC: 4249949. DOI: 10.1167/iovs.14-15179. View

Chao W, DAmore P . IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 2008; 19(2):111-20. PMC: 2314671. DOI: 10.1016/j.cytogfr.2008.01.005. View

Martin-Kleiner I, Gall Troselj K . Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. Cancer Lett. 2009; 289(1):11-22. DOI: 10.1016/j.canlet.2009.06.036. View

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

Raykha C, Crawford J, Burry A, Drosdowech D, Faber K, Gan B . IGF2 expression and β-catenin levels are increased in Frozen Shoulder Syndrome. Clin Invest Med. 2014; 37(4):E262-7. DOI: 10.25011/cim.v37i4.21733. View

Xing S, Tian Z, Zheng W, Yang W, Du N, Gu Y . Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. Mol Cancer. 2021; 20(1):9. PMC: 7786912. DOI: 10.1186/s12943-020-01295-2. View

Liu J, Hu X, Chen J, Li X, Wang L, Wang B . Pericentral hepatocytes produce insulin-like growth factor-2 to promote liver regeneration during selected injuries in mice. Hepatology. 2017; 66(6):2002-2015. DOI: 10.1002/hep.29340. View

Bayati P, Taherian M, Assarehzadegan M, Soleimani M, Poormoghim H, Mojtabavi N . Induced Pluripotent Stem-cells Inhibit Experimental Bleomycin-induced Pulmonary Fibrosis through Regulation of the Insulin-like Growth Factor Signaling. Iran J Allergy Asthma Immunol. 2022; 21(3):263-272. DOI: 10.18502/ijaai.v21i3.9800. View

Sciacca L, Costantino A, Pandini G, MINEO R, Frasca F, Scalia P . Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene. 1999; 18(15):2471-9. DOI: 10.1038/sj.onc.1202600. View

10.

Hu Y, Hu Y, Liu D, Yu J, Liu D . [Screening and bioinformatics analysis of differentially expressed genes in hyperplastic scar]. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34(7):939-44. View

11.

Liu M, Roth A, Yu M, Morris R, Bersani F, Rivera M . The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. Genes Dev. 2013; 27(23):2543-8. PMC: 3861668. DOI: 10.1101/gad.224170.113. View

12.

Kumar D, Das M, Oberg A, Sahoo D, Wu P, Sauceda C . Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma. Adv Sci (Weinh). 2022; 9(21):e2105120. PMC: 9313545. DOI: 10.1002/advs.202105120. View

13.

Denley A, Cosgrove L, Booker G, Wallace J, Forbes B . Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 2005; 16(4-5):421-39. DOI: 10.1016/j.cytogfr.2005.04.004. View

14.

Vella V, Nicolosi M, Cantafio P, Massimino M, Lappano R, Vigneri P . DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop. Endocr Relat Cancer. 2018; 26(1):197-214. DOI: 10.1530/ERC-18-0310. View

15.

Kaps L, Schuppan D . Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells. 2020; 9(9). PMC: 7563527. DOI: 10.3390/cells9092027. View

16.

Azzi S, Habib W, Netchine I . Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation. Curr Opin Endocrinol Diabetes Obes. 2013; 21(1):30-8. DOI: 10.1097/MED.0000000000000037. View

17.

Khan I, Pant I, Narra S, Radhesh R, Ranganathan K, Rao S . Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut. J Cell Mol Med. 2015; 19(10):2397-412. PMC: 4594681. DOI: 10.1111/jcmm.12622. View

18.

Hsu E, Feghali-Bostwick C . Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol. 2008; 172(6):1580-90. PMC: 2408418. DOI: 10.2353/ajpath.2008.071021. View

19.

van Beuge M, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L . Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. Pharm Res. 2011; 28(8):2045-54. PMC: 3130909. DOI: 10.1007/s11095-011-0430-9. View

20.

Chiefari E, Mirabelli M, La Vignera S, Tanyolac S, Foti D, Aversa A . Insulin Resistance and Cancer: In Search for a Causal Link. Int J Mol Sci. 2021; 22(20). PMC: 8540232. DOI: 10.3390/ijms222011137. View